Although the exact role(s) of NMNAT2 have yet to be fully elucidated, there is considerable evidence that it may promote cancer cell survival by accelerating glycolysis via a mechanism that includes a reduction in the expression of the transcriptional regulator sirtuin SIRT6 [47]. The gene discussed is NMNAT2; the disease is cancer.